• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎支原体肺炎患儿血清中ESM-1和Syndecan-1的表达及其与疾病严重程度的关系

Serum expression of ESM-1 and Syndecan-1 and its relationship with disease severity in children with Mycoplasma pneumoniae pneumonia.

作者信息

Yu Yanjuan, Su Yanyan, Jin Xiuhong, Zhang Xiangfeng, Yang Yeran, Shen Yuelin

机构信息

Respiratory Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, 450018, China.

Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, NO.56, Nanlishi Road, Beijing, 100045, China.

出版信息

Ital J Pediatr. 2025 Aug 5;51(1):247. doi: 10.1186/s13052-025-02105-5.

DOI:10.1186/s13052-025-02105-5
PMID:40764585
Abstract

BACKGROUND

This study aim to investigate the role of endothelial damage in the pathogenesis of Mycoplasma pneumoniae pneumonia (MPP) by comparing serum levels of endothelial cell-specific molecule 1 (ESM-1) and Syndecan-1 in patients with varying degrees of MPP severity. Additionally, we aim to explore the relationship between the production of ESM-1 and Syndecan-1 and the severity of MPP, inflammation, as well as hypercoagulative state in children.

METHODS

A prospective, observational study that included clinical manifestations, laboratory tests, and serum ESM-1 and Syndecan-1 assays. The correlation between ESM-1 and Syndecan-1 levels with inflammatory markers and coagulation markers was analyzed. Multivariate logistic regression analysis was conducted to identify significant risk factors for Severe Mycoplasma pneumoniae pneumonia (SMPP).

RESULTS

A total of 179 children with MPP and 40 healthy volunteers were enrolled. Serum ESM-1 and Syndecan-1 levels were significantly elevated in children with MPP compared to the healthy children (all P < 0.05). A multivariate analysis revealed that ESM-1, Syndecan-1, D-dimer and LDH were the significant predictors of SMPP, with odds ratios of 1.034, 1.002, 5.042 and 1.014, respectively. The optimal cutoff values of ESM-1, Syndecan-1, D-dimer and LDH for predicting SMPP were 79.67 ng/mL, 3219.35 pg/mL, 0.67 µg/mL and 365.00 U/L, respectively.

CONCLUSIONS

ESM-1, Syndecan-1, D-dimer, and LDH can serve as independent predictors for SMPP. The interaction between endothelial damage, excessive inflammatory response, and hypercoagulable state collectively contributes to the development and progression of SMPP.

摘要

背景

本研究旨在通过比较不同严重程度的支原体肺炎(MPP)患者血清中内皮细胞特异性分子1(ESM-1)和Syndecan-1的水平,探讨内皮损伤在MPP发病机制中的作用。此外,我们旨在探讨儿童ESM-1和Syndecan-1的产生与MPP严重程度、炎症以及高凝状态之间的关系。

方法

一项前瞻性观察性研究,包括临床表现、实验室检查以及血清ESM-1和Syndecan-1检测。分析了ESM-1和Syndecan-1水平与炎症标志物和凝血标志物之间的相关性。进行多因素逻辑回归分析以确定重症支原体肺炎(SMPP)的重要危险因素。

结果

共纳入179例MPP患儿和40名健康志愿者。与健康儿童相比,MPP患儿血清ESM-1和Syndecan-1水平显著升高(均P < 0.05)。多因素分析显示,ESM-1、Syndecan-1、D-二聚体和乳酸脱氢酶(LDH)是SMPP的重要预测指标,其比值比分别为1.034、1.002、5.042和1.014。预测SMPP的ESM-1、Syndecan-1、D-二聚体和LDH的最佳截断值分别为79.67 ng/mL、3219.35 pg/mL、0.67 μg/mL和365.00 U/L。

结论

ESM-1、Syndecan-1、D-二聚体和LDH可作为SMPP的独立预测指标。内皮损伤、过度炎症反应和高凝状态之间的相互作用共同促进了SMPP的发生和发展。

相似文献

1
Serum expression of ESM-1 and Syndecan-1 and its relationship with disease severity in children with Mycoplasma pneumoniae pneumonia.肺炎支原体肺炎患儿血清中ESM-1和Syndecan-1的表达及其与疾病严重程度的关系
Ital J Pediatr. 2025 Aug 5;51(1):247. doi: 10.1186/s13052-025-02105-5.
2
The predictive value of MUC5AC levels in the sputum of children with pneumonia treated with fiberbronchoscopy.纤维支气管镜治疗的肺炎患儿痰液中MUC5AC水平的预测价值
Microbiol Spectr. 2025 Jul 2:e0010325. doi: 10.1128/spectrum.00103-25.
3
Assessment of serum parameters caused by the outbreak of mycoplasma pneumoniae pneumonia in children after COVID-19.新冠疫情后儿童支原体肺炎爆发所致血清参数评估
Sci Rep. 2025 Aug 3;15(1):28306. doi: 10.1038/s41598-025-13555-6.
4
Multi-omics analysis of human plasma reveals reprogramming of tryptophan metabolism associated with inflammation in Mycoplasma pneumoniae pneumonia in children.对人血浆的多组学分析揭示了儿童支原体肺炎中与炎症相关的色氨酸代谢重编程。
J Infect. 2025 Jul;91(1):106525. doi: 10.1016/j.jinf.2025.106525. Epub 2025 May 31.
5
Diagnostic values of soluble triggering receptor expressed on myeloid cells (sTREM-1) and interferon-inducible protein-10 (IP-10) for severe mycoplasma pneumoniae pneumonia in children.髓系细胞表面可溶性触发受体(sTREM-1)和干扰素诱导蛋白-10(IP-10)对儿童重症支原体肺炎的诊断价值
Clinics (Sao Paulo). 2024 Apr 27;79:100361. doi: 10.1016/j.clinsp.2024.100361. eCollection 2024.
6
Prediction of risk factors of plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia.重症肺炎支原体肺炎患儿塑料支气管炎危险因素的预测
Biomed Eng Online. 2025 Jun 21;24(1):75. doi: 10.1186/s12938-025-01410-8.
7
Volume ratio of pulmonary lesions as a novel indicator for predicting the occurrence of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.肺部病变体积比作为预测支原体肺炎患儿发生塑型性支气管炎的新指标。
Eur J Pediatr. 2025 Jun 9;184(7):409. doi: 10.1007/s00431-025-06251-0.
8
A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era.新冠疫情后时代儿童和成人肺炎支原体肺炎的诊断与治疗方法比较
Eur J Clin Microbiol Infect Dis. 2025 Apr 29. doi: 10.1007/s10096-025-05142-4.
9
Diagnostic efficacy of Mycoplasma pneumoniae antibody and procalcitonin in children with Mycoplasma pneumonia.肺炎支原体抗体及降钙素原在儿童支原体肺炎中的诊断效能
BMC Pulm Med. 2025 Aug 1;25(1):370. doi: 10.1186/s12890-025-03870-z.
10
Clinical features and risk factors for severe macrolide-resistant mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study.23S rRNA A2063G突变所致重症大环内酯类耐药肺炎支原体肺炎的临床特征及危险因素:一项回顾性观察研究
Eur J Clin Microbiol Infect Dis. 2025 Jul 17. doi: 10.1007/s10096-025-05215-4.

本文引用的文献

1
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study.新冠疫情限制措施后肺炎支原体再度出现的全球时空动态:一项流行病学与传播建模研究
Lancet Microbe. 2025 Apr;6(4):101019. doi: 10.1016/j.lanmic.2024.101019. Epub 2025 Feb 27.
2
Pentavalent Rotavirus Vaccine Coverage and Trends in Rotavirus Detection Before and After This Vaccination in Chengdu, China.中国成都五价轮状病毒疫苗接种率及接种前后轮状病毒检测趋势
Pediatr Infect Dis J. 2024 Nov 1;43(11):e397-e399. doi: 10.1097/INF.0000000000004441. Epub 2024 Jul 2.
3
A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.
儿童普通型与重症肺炎支原体肺炎的对比研究。
BMC Infect Dis. 2024 Apr 26;24(1):449. doi: 10.1186/s12879-024-09340-x.
4
The Concept of Thromboinflammation.血栓炎症概念。
Hamostaseologie. 2024 Feb;44(1):21-30. doi: 10.1055/a-2178-6491. Epub 2024 Feb 28.
5
Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis.儿童肺炎支原体肺炎合并肺血栓栓塞症的临床特征及危险因素分析。
Pediatr Infect Dis J. 2024 Jun 1;43(6):505-510. doi: 10.1097/INF.0000000000004287. Epub 2024 Feb 15.
6
Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China.中国大环内酯类耐药流行克隆株导致支原体肺炎的再现。
Lancet Microbe. 2024 Jun;5(6):e515. doi: 10.1016/S2666-5247(23)00405-6. Epub 2024 Jan 17.
7
Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity.肺炎支原体肺炎患儿凝血标志物变化及其对支原体严重程度的预测价值。
Ital J Pediatr. 2023 Oct 20;49(1):143. doi: 10.1186/s13052-023-01545-1.
8
Fibrinogen and fibrin: synthesis, structure, and function in health and disease.纤维蛋白原和纤维蛋白:在健康和疾病中的合成、结构和功能。
J Thromb Haemost. 2023 Nov;21(11):3005-3015. doi: 10.1016/j.jtha.2023.08.014. Epub 2023 Aug 23.
9
Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study.儿童重症肺炎支原体肺炎合并肺部并发症的临床特征:一项回顾性研究。
Pediatr Pulmonol. 2023 Oct;58(10):2815-2822. doi: 10.1002/ppul.26593. Epub 2023 Jul 11.
10
Systematic Review of Endocan as a Potential Biomarker of COVID-19.系统评价内脂素作为 COVID-19 潜在生物标志物的研究
Angiology. 2024 Feb;75(2):107-115. doi: 10.1177/00033197231152941. Epub 2023 Jan 21.